hFABP as a Marker for Ischaemia in Angioplasty Patients

• Research type

  Research Study

• Full title

  Heart-type Fatty Acid Binding Protein as a Marker for Ischaemia in Patients Undergoing Percutaneous Coronary Intervention

• IRAS ID

  151788

• Contact name

  Paul Collinson

• Contact email

  paul.collinson@stgeorges.nhs.uk

• Sponsor organisation

  St.George's University of London

• Research summary

  When patients undergo PCI, including angioplasty, they may experience reduced blood flow (ischaemia) in the heart during this procedure. hFABP is a cardiac protein shown to be released into the blood early in cardiac injury and may indicate the presence of ischaemia. We will be testing blood samples for the presence of hFABP before and after the PCI procedure. If hFABP levels are raised in blood samples taken from angioplasty patients this could indicate the presence of ischaemia and indentify hFABP as a potential marker for the future. Since there is currently no marker for ischaemia available, this could greatly improve the way cardiac patients are treated.

• REC name

  Yorkshire & The Humber - Leeds East Research Ethics Committee

• REC reference

  14/YH/1008

• Date of REC Opinion

  6 Jun 2014

• REC opinion

  Further Information Favourable Opinion